3Suppliers
4Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Autonomix Medical, Inc. (AMIX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships
2Distinct source URLs
6High confidence
0.806Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Autonomix Medical, Inc. Suppliers

TickerNameConfidenceEvidence
MAXIM-GROUP-LLC MAXIM-GROUP-LLC 92% In connection with the above November 2025 Offering, on November 18, 2025, the Company entered into a placement agency agreement with Maxim Group LLC (the “Placement Agent”)
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from AMIX graph: a limited number of regions or Key Opinion Leaders ("KOLs") to refine and optimize the commercial strategy prior to na…
JNJ Johnson & Johnson 72% a limited number of regions or Key Opinion Leaders ("KOLs") to refine and optimize the commercial strategy prior to national and global deployment. Our commercialization approach may include either a…

Autonomix Medical, Inc. Customers

TickerNameConfidenceEvidence
RF-INNOVATIONS-INC RF-INNOVATIONS-INC 85% - option expense related to the stock option cancellation agreements stated above. During the three and nine months ended December 31, 2024 , the Company recorded stock-based compensation - option ex…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from AMIX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AMIX graph: Reciprocal relationship from JNJ grap…
JNJ Johnson & Johnson 72% a limited number of regions or Key Opinion Leaders ("KOLs") to refine and optimize the commercial strategy prior to national and global deployment. Our commercialization approach may include either a…
MAXIM-GROUP-LLC MAXIM-GROUP-LLC 62% nt Agent’s commission and fees of $450 thousand and other offering expenses of $ 36 thousand and excluding the proceeds from the exercise of the Warrants. As of December 31, 2025, all 4,501,666 of t…

Autonomix Medical, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AMIX-DEBT-7725 Warrants outstanding: 0.01 90% xbrl warrant detail from xbrl 2025-03-31.
AMIX-DEBT Debt stack $2.6M 90% Market cache reports total debt of $2.6M.
AMIX-DEBT-7726 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-03-31.

Autonomix Medical, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Autonomix Medical, Inc..

Autonomix Medical, Inc. Ownership

HolderNameConfidenceEvidence
AMIX-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC GEODE CAPITAL MANAGEMENT, LLC 90% 13F overlay lists GEODE CAPITAL MANAGEMENT, LLC as top holder; 15 tracked holders.

Autonomix Medical, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
JNJ Johnson & Johnson 100.00 1 ['customer', 'supplier']
CVRX CVRx, Inc. 50.00 2
ALC Alcon Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
AORT Artivion, Inc. 50.00 2
AVBP ArriVent BioPharma, Inc. 50.00 2
CYTOF Altamira Therapeutics Ltd. 50.00 2
CBIH Cannabis Bioscience International Holdings, Inc. 50.00 2
BNR Burning Rock Biotech Limited 50.00 2
BNRG Brenmiller Energy Ltd 50.00 2
AVTX Avalo Therapeutics, Inc. 50.00 2
CSTE Caesarstone Ltd. 50.00 2
DYAI Dyadic International, Inc. 50.00 2
SNNUF Smith & Nephew plc 50.00 2
ANIK Anika Therapeutics, Inc. 50.00 2
ATRA Atara Biotherapeutics, Inc. 50.00 2
EVFM Evofem Biosciences, Inc. 50.00 2
CLGN CollPlant Biotechnologies Ltd. 50.00 2
BLCO Bausch + Lomb Corporation 50.00 2
BLLN BillionToOne, Inc. 50.00 2
🔐
AMIX
Unlock AMIX Supply Chain Data
Verified relationships include:
MAXIM-GROUP-LLCMAXIM-GROUP-LLCSupplier92%
JNJJohnson & JohnsonSupplier72%
RF-INNOVATIONS-INCRF-INNOVATIONS-INCCustomer85%
JNJJohnson & JohnsonCustomer72%
+7 more relationships locked
Subscribe — View plans →